Braster S.A.
Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more
Braster S.A. (BRA) - Total Liabilities
Latest total liabilities as of March 2024: zł23.68 Million PLN
Based on the latest financial reports, Braster S.A. (BRA) has total liabilities worth zł23.68 Million PLN as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Braster S.A. - Total Liabilities Trend (2011–2023)
This chart illustrates how Braster S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Braster S.A. Competitors by Total Liabilities
The table below lists competitors of Braster S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ReShape Lifesciences Inc
NASDAQ:RSLS
|
USA | $3.20 Million |
|
Braille Energy Systems Inc
V:BES
|
Canada | CA$3.34 Million |
|
Propanc Biopharma, Inc. Common Stock
PINK:PPCB
|
USA | $4.66 Million |
|
Ateliers Mecaniques D’Indonesie Tbk PT
JK:AMIN
|
Indonesia | Rp114.00 Billion |
|
Golden Sun Education Group Ltd
NASDAQ:GSUN
|
USA | $15.13 Million |
|
RALPH LAUREN-A
BE:PRL
|
Germany | €4.36 Billion |
|
Rumbu Holdings Ltd.
V:RMB
|
Canada | CA$9.68 Million |
|
TERABYTE PLUS PUBLIC COMPANY LIMITED
BK:TERA
|
Thailand | ฿239.91 Million |
Liability Composition Analysis (2011–2023)
This chart breaks down Braster S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -4.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Braster S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Braster S.A. (2011–2023)
The table below shows the annual total liabilities of Braster S.A. from 2011 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | zł23.55 Million | -0.46% |
| 2022-12-31 | zł23.65 Million | +7.65% |
| 2021-12-31 | zł21.97 Million | -21.46% |
| 2020-12-31 | zł27.97 Million | -0.37% |
| 2019-12-31 | zł28.08 Million | +10.06% |
| 2018-12-31 | zł25.51 Million | +2.83% |
| 2017-12-31 | zł24.81 Million | -17.29% |
| 2016-12-31 | zł30.00 Million | +429.20% |
| 2015-12-31 | zł5.67 Million | +17.81% |
| 2014-12-31 | zł4.81 Million | +1015.18% |
| 2013-12-31 | zł431.41K | +24.34% |
| 2012-12-31 | zł346.95K | -50.18% |
| 2011-12-31 | zł696.40K | -- |